These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3438582)

  • 1. Bioavailability and pharmacokinetics of a new controlled-release theophylline preparation in the form of capsules containing pellets.
    Valenti S; Crimi P; Brusasco V
    Respiration; 1987; 52(3):195-200. PubMed ID: 3438582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absolute bioavailability of theophylline from a sustained-release formulation using different intravenous reference infusions.
    Steinijans VW; Schulz HU; Böhm A; Beier W
    Eur J Clin Pharmacol; 1987; 33(5):523-6. PubMed ID: 3428347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theophylline pharmacokinetics following single and repeated administration of slow-release capsules.
    Torrent J; Izquierdo I; Barbanoj MJ; Obach R; Nomen M; Jane F
    Eur J Drug Metab Pharmacokinet; 1988; 13(4):225-30. PubMed ID: 3243316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of theophylline. Repeated single evening administration of Pulmo-Timelets slow-release capsules in comparison with theophylline slow-release tablets].
    Heusinger JH; Breuel HP; Behrendt WA; Wolfstädter HD
    Fortschr Med; 1989 Nov; 107(32):692-6. PubMed ID: 2689314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic profile of a new sustained-release theophylline pellet formulation for once-daily evening administration.
    Steinijans VW; Sauter R; Böhm A; Staudinger H
    Arzneimittelforschung; 1988 Aug; 38(8A):1241-50. PubMed ID: 3190813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of a slow-release theophylline preparation in horses after intravenous and oral administration.
    Errecalde JO; Landoni MF
    Vet Res Commun; 1992; 16(2):131-8. PubMed ID: 1496815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The bioavailability of 4 sustained-release theophylline preparations from the Chilean market].
    Biagini L; Zamora P; Chávez H; Saavedra I
    Rev Med Chil; 1990 Nov; 118(11):1241-6. PubMed ID: 2152650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the bioavailability and pharmacokinetics of two extended-release theophylline formulations in dogs.
    Bach JE; Kukanich B; Papich MG; McKiernan BC
    J Am Vet Med Assoc; 2004 Apr; 224(7):1113-9. PubMed ID: 15074856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bioavailability of theophylline in a new oral sustained-release preparation (author's transl)].
    Schneider GF; Heese GU; Huber HJ; Janzen N; Jünger H; Moser C; Stanislaus F
    Arzneimittelforschung; 1981; 31(9):1489-97. PubMed ID: 7197962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of food on the bioavailability of theophylline from a sustained-released theophylline preparation.
    Lohmann A; Dingler E; Sommer W
    Arzneimittelforschung; 1991 Jul; 41(7):732-4. PubMed ID: 1772462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of an extended-release theophylline product in cats.
    Guenther-Yenke CL; McKiernan BC; Papich MG; Powell E
    J Am Vet Med Assoc; 2007 Sep; 231(6):900-6. PubMed ID: 17867974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Absorption profile and absolute bioavailability of a theophylline--retard preparation].
    Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
    Arzneimittelforschung; 1990 Nov; 40(11):1218-24. PubMed ID: 2085333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once-daily dosing of a new ultrasustained-release theophylline preparation.
    Van den Brande P; Nys J; Tjandramaga TB; Verhelst F; Demedts M
    Respiration; 1987; 52(2):144-53. PubMed ID: 3671893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation].
    Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
    Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the influence of food on the absorption of theophylline from a controlled-release preparation.
    Pabst G; Weber W; Müller M; Barkworth MF
    Arzneimittelforschung; 1994 Mar; 44(3):333-7. PubMed ID: 8192698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Theophylline-retard preparations: relation between drug liberation in vitro and their behavior in the human body].
    Beerbaum H; Kulpe K; Seidel KH; Zand G; Nussbücker B; Wilke A; Rentsch E; Wiesner B; Iwainsky H
    Pharmazie; 1988 May; 43(5):325-9. PubMed ID: 3174809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of food on the absorption of controlled-release theophylline in mini-swine.
    Shiu GK; Sager AO; Velagapudi RB; Prasad VK; Skelly JP
    Pharm Res; 1988 Jan; 5(1):48-52. PubMed ID: 3244609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theophylline absorption from two sustained-release products. Implications for therapeutic drug monitoring.
    Rogers RJ; Wiener MB; Hill MR; Szefler SJ
    Am Rev Respir Dis; 1987 Nov; 136(5):1168-73. PubMed ID: 3674579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of enteral feedings on sustained-release theophylline absorption.
    Plezia PM; Thornley SM; Kramer TH; Armstrong EP
    Pharmacotherapy; 1990; 10(5):356-61. PubMed ID: 2122422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.